Herpes Sores
- Manufacturer
- Newton Laboratories, Inc.
- Effective date
- 2011-06-01
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 02:05:26
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
HERPES SORES Formulated for associated symptoms of Herpes Simplex and Herpes Zoster such as itching, tingling, crusting and painful skin eruptions or ulcerations.
DOSAGE & ADMINISTRATION SECTION
Directions: ORAL USE ONLY - SHAKE WELL. Ages 12 and up, take 6 drops orally (ages 0 to 11, give 3 drops) as needed or as directed by a healthcare professional.
ACTIVE INGREDIENT SECTION
Arsenicum alb. 15x, Bryonia 15x, Cantharis 15x, Chelidonium majus 15x, Cistus canadensis 15x, Conium 15x, Croton 15x, Dulcamara 15x, Graphites 15x, Kali bic. 15x, Lycopodium 15x, Mezereum 15x, Nux vom. 15x, Petroleum 15x, Pulsatilla 15x, Ranunc. bulb. 15x, Rhus toxicodendron 15x, Sarsaparilla 15x, Sepia 15x, Sulphur 15x, Thuja occ. 15x, Echinacea 8x, Hypericum 8x, Echinacea 3x, Hypericum 3x.
PURPOSE SECTION
Formulated for associated symptoms of Herpes Simplex and Herpes Zoster such as itching, tingling, crusting and painful skin eruptions or ulcerations.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: USP Purified Water; USP Gluten-free, non-GMO, organic cane dispensing alcohol 20%.
QUESTIONS? SECTION
www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256
WARNINGS SECTION
Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.
PREGNANCY OR BREAST FEEDING SECTION
Consult a licensed healthcare professional if pregnant or nursing or if symptoms worsen or persist for more than a few days.
KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
PACKAGE LABEL.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 63f39a63-5cd1-4016-bd86-2bbb0f6c3139 | Product name | 3 | 20240506 |
| e5a77e9c-c528-733a-173d-914a234c024b | Product name | 5 | 20240506 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55714-4452-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-49a8-f424-e053-dadaa90a57ce | Herpes Sores |
| 55714-4452-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-49a8-f424-e053-dadaa90a57ce | Herpes Sores |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55714-4452-1 | Herpes Sores | 29.57 mL in 1 BOTTLE, GLASS | LIQUID | 29.57 | 3 | |
| 55714-4452-2 | Herpes Sores | 59.14 mL in 1 BOTTLE, GLASS | LIQUID | 59.14 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55714-4452 | HERPES SORES (ARSENICUM ALB., BRYONIA, CANTHARIS, CHELIDONIUM MAJUS, CISTUS CANADENSIS, CONIUM, CROTON, DULCAMARA, GRAPHITES, KALI BIC., LYCOPODIUM, MEZEREUM, NUX VOM., PETROLEUM, PULSATILLA, RANUNC. BULB., RHUS TOXICODENDRON, SARSAPARILLA, SEPIA, SULPHUR, THUJA OCC., ECHINACEA, HYPERICUM) LIQUID [NEWTON LABORATORIES, INC.] | 3 | Legacy NDC, 2 package rows | 20140206_7debaeec-50fc-a03b-dbab-83a6770f9aa7.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Arsenic Trioxide | ACTIVE INGREDIENT | S7V92P67HO | 3 | |
| Bryonia Alba Root | ACTIVE INGREDIENT | T7J046YI2B | 3 | |
| Chelidonium Majus | ACTIVE INGREDIENT | 7E889U5RNN | 3 | |
| Conium Maculatum Flowering Top | ACTIVE INGREDIENT | Q28R5GF371 | 3 | |
| Croton Tiglium Seed | ACTIVE INGREDIENT | 0HK2GZK66E | 3 | |
| Daphne Mezereum Bark | ACTIVE INGREDIENT | X2N6E405GV | 3 | |
| Echinacea, Unspecified | ACTIVE INGREDIENT | 4N9P6CC1DX | 3 | |
| Graphite | ACTIVE INGREDIENT | 4QQN74LH4O | 3 | |
| Helianthemum Canadense | ACTIVE INGREDIENT | 46G3W789Q3 | 3 | |
| Hypericum Perforatum | ACTIVE INGREDIENT | XK4IUX8MNB | 3 | |
| Kerosene | ACTIVE INGREDIENT | 1C89KKC04E | 3 | |
| Lycopodium Clavatum Spore | ACTIVE INGREDIENT | C88X29Y479 | 3 | |
| Lytta Vesicatoria | ACTIVE INGREDIENT | 3Q034RO3BT | 3 | |
| Potassium Dichromate | ACTIVE INGREDIENT | T4423S18FM | 3 | |
| Pulsatilla Vulgaris | ACTIVE INGREDIENT | I76KB35JEV | 3 | |
| Ranunculus Bulbosus | ACTIVE INGREDIENT | AEQ8NXJ0MB | 3 | |
| Sepia Officinalis Juice | ACTIVE INGREDIENT | QDL83WN8C2 | 3 | |
| Smilax Regelii Root | ACTIVE INGREDIENT | 2H1576D5WG | 3 | |
| Solanum Dulcamara Top | ACTIVE INGREDIENT | KPS1B1162N | 3 | |
| Strychnos Nux-vomica Seed | ACTIVE INGREDIENT | 269XH13919 | 3 | |
| Sulfur | ACTIVE INGREDIENT | 70FD1KFU70 | 3 | |
| Thuja Occidentalis Leafy Twig | ACTIVE INGREDIENT | 1NT28V9397 | 3 | |
| Toxicodendron Pubescens Leaf | ACTIVE INGREDIENT | 6IO182RP7A | 3 | |
| Arsenic Cation (3+) | ACTIVE MOIETY | C96613F5AV | 3 | |
| Bryonia Alba Root | ACTIVE MOIETY | T7J046YI2B | 3 | |
| Chelidonium Majus | ACTIVE MOIETY | 7E889U5RNN | 3 | |
| Conium Maculatum Flowering Top | ACTIVE MOIETY | Q28R5GF371 | 3 | |
| Croton Tiglium Seed | ACTIVE MOIETY | 0HK2GZK66E | 3 | |
| Daphne Mezereum Bark | ACTIVE MOIETY | X2N6E405GV | 3 | |
| Dichromate Ion | ACTIVE MOIETY | 9LKY4BFN2V | 3 | |
| Echinacea, Unspecified | ACTIVE MOIETY | 4N9P6CC1DX | 3 | |
| Graphite | ACTIVE MOIETY | 4QQN74LH4O | 3 | |
| Helianthemum Canadense | ACTIVE MOIETY | 46G3W789Q3 | 3 | |
| Hypericum Perforatum | ACTIVE MOIETY | XK4IUX8MNB | 3 | |
| Kerosene | ACTIVE MOIETY | 1C89KKC04E | 3 | |
| Lycopodium Clavatum Spore | ACTIVE MOIETY | C88X29Y479 | 3 | |
| Lytta Vesicatoria | ACTIVE MOIETY | 3Q034RO3BT | 3 | |
| Pulsatilla Vulgaris | ACTIVE MOIETY | I76KB35JEV | 3 | |
| Ranunculus Bulbosus | ACTIVE MOIETY | AEQ8NXJ0MB | 3 | |
| Sepia Officinalis Juice | ACTIVE MOIETY | QDL83WN8C2 | 3 | |
| Smilax Regelii Root | ACTIVE MOIETY | 2H1576D5WG | 3 | |
| Solanum Dulcamara Top | ACTIVE MOIETY | KPS1B1162N | 3 | |
| Strychnos Nux-vomica Seed | ACTIVE MOIETY | 269XH13919 | 3 | |
| Sulfur | ACTIVE MOIETY | 70FD1KFU70 | 3 | |
| Thuja Occidentalis Leafy Twig | ACTIVE MOIETY | 1NT28V9397 | 3 | |
| Toxicodendron Pubescens Leaf | ACTIVE MOIETY | 6IO182RP7A | 3 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 3 |
Products#
Every source-derived product name is available through these pages.
- Herpes Sores
- Arsenicum alb., Bryonia, Cantharis, Chelidonium majus, Cistus canadensis, Conium, Croton, Dulcamara, Graphites, Kali bic., Lycopodium, Mezereum, Nux vom., Petroleum, Pulsatilla, Ranunc. bulb., Rhus toxicodendron, Sarsaparilla, Sepia, Sulphur, Thuja occ., Echinacea, Hypericum
- Arsenic Trioxide
- Arsenic Cation (3+)
- Bryonia Alba Root
- Lytta Vesicatoria
- Chelidonium Majus
- Helianthemum Canadense
- Conium Maculatum Flowering Top
- Croton Tiglium Seed
- Solanum Dulcamara Top
- Graphite
- Potassium Dichromate
- Dichromate Ion
- Lycopodium Clavatum Spore
- Daphne Mezereum Bark
- Strychnos Nux-vomica Seed
- Kerosene
- Pulsatilla Vulgaris
- Ranunculus Bulbosus
- Toxicodendron Pubescens Leaf
- Smilax Regelii Root
- Sepia Officinalis Juice
- Sulfur
- Thuja Occidentalis Leafy Twig
- Echinacea, Unspecified
- Hypericum Perforatum
- Alcohol
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55714-4452 | 55714-4452-1, 55714-4452-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 46ffd1dd-d60b-108c-da5f-d09a671b0fd9 | 7debaeec-50fc-a03b-dbab-83a6770f9aa7 | 2011-06-01 | Warnings | 46ffd1dd-d60b-108c-da5f-d09a671b0fd9 7debaeec-50fc-a03b-dbab-83a6770f9aa7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
